Teva Pharmaceutical Industries Revenue Quarterly:
4.901B for March 31, 2013Teva Pharmaceutical Industries Historical Revenue Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 4.901B |
| Dec. 31, 2012 | 5.249B |
| Sept. 30, 2012 | 4.972B |
| June 30, 2012 | 4.994B |
| March 31, 2012 | 5.102B |
| Dec. 31, 2011 | 5.676B |
| Sept. 30, 2011 | 4.344B |
| June 30, 2011 | 4.212B |
| March 31, 2011 | 4.08B |
| Dec. 31, 2010 | 4.418B |
| Sept. 30, 2010 | 4.25B |
| June 30, 2010 | 3.80B |
| March 31, 2010 | 3.653B |
| Dec. 31, 2009 | 3.802B |
| Sept. 30, 2009 | 3.55B |
| June 30, 2009 | 3.40B |
| March 31, 2009 | 3.147B |
| Dec. 31, 2008 | 2.848B |
| Sept. 30, 2008 | 2.842B |
| June 30, 2008 | 2.823B |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.
While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More
TEVA Revenue Quarterly Benchmarks
| Companies | |
|---|---|
| Alexza Pharmaceuticals | 0.729M |
| Mylan | 1.631B |
| Akorn | 73.85M |
TEVA Revenue Quarterly Rankings
| Overall |
97th percentile 240 of 8002 |
| Sector |
96th percentile 20 of 650 in Healthcare |
| Industry |
98th percentile 1 of 65 in Drug Manufacturers - Specialty & Generic |
TEVA Revenue Quarterly Range, Past 5 Years
| Minimum | 2.823B | Jun 2008 |
| Maximum | 5.676B | Dec 2011 |
| Average | 4.103B |
